A thought leadership article in Contract Pharma discussing the key findings from ICON's and Pharma Intelligence's survey of pharmaceutical executives and professionals which examined the key challenges of declining research and development (R&D) efficiency. The article explores the need for a holistic and integrated approach to improve clinical trial efficiencies.